“Creating Hope” and Other Incentives for Drug Development for Children-Reference-Cited by-同舟云学术

“Creating Hope” and Other Incentives for Drug Development for Children

Published:2011-01-19 Issue:66 Volume:3 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Connor Edward¹²,Cure Pablo¹

Affiliation:

1. Office of Innovation Development and Investigational Therapeutics, Clinical and Translational Science Institute, Children’s Research Institute, Children’s National Medical Center, Washington, DC 20010, USA.

2. Departments of Pediatrics and Microbiology, Immunology, and Tropical Medicine, The George Washington School of Medicine and Health Sciences, Washington, DC 20037, USA.

Abstract

Proposed legislation would provide financial benefits for companies that develop drugs for treating rare pediatric diseases.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference19 articles.

1. Ensuring Safe and Effective Medications for Children

2. Pediatric Drug Labeling

3. The economics of pediatric formulation development for off-patent drugs

4. More Than Baby Steps: Perspectives on Pediatric Translational Research

5. J. L. Goodman Treating Rare and Neglected Pediatric Diseases: Promoting the Development of New Treatments and Cures. Statement before the Committee on Health Education Labor and Pensions 21 July 2010 www.fda.gov/NewsEvents/Testimony/ucm219765.htm.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new dawn for orphan diseases in dermatology: The transformative potential of digital twins;Journal of the European Academy of Dermatology and Venereology;2024-05-07

2. Fostering open collaboration in drug development for paediatric brain tumours;Biochemical Society Transactions;2019-09-24

3. Addressing the needs of Canadians with rare diseases: an evaluation of orphan drug incentives;Journal of Law and the Biosciences;2018-08-31

4. Therapeutic and Other Misconceptions in Clinical Trials for Paediatric Genetic Disorders;eLS;2018-07-13

5. Generic Substitution of Orphan Drugs for the Treatment of Rare Diseases: Exploring the Potential Challenges;Drugs;2018-02-20